Published in Medical Devices and Surgical Technology Week, December 24th, 2006
The charge is primarily associated with intellectual property assets acquired from Sub-Q Inc. in March 2005.
"It is not likely that Merit will pursue the product associated with the intellectual property we acquired due to other priorities and opportunities, and it is prudent to take this action," said Fred P. Lampropoulos, Merit's chairman and chief executive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.